Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008–2010)

Ilaria Lippi Department of Veterinary Science, University of Pisa, San Piero a Grado, Pisa, 56122, Italy.

Search for other papers by Ilaria Lippi in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Grazia Guidi Department of Veterinary Science, University of Pisa, San Piero a Grado, Pisa, 56122, Italy.

Search for other papers by Grazia Guidi in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Veronica Marchetti Department of Veterinary Science, University of Pisa, San Piero a Grado, Pisa, 56122, Italy.

Search for other papers by Veronica Marchetti in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Rosalba Tognetti Department of Veterinary Science, University of Pisa, San Piero a Grado, Pisa, 56122, Italy.

Search for other papers by Rosalba Tognetti in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Valentina Meucci Department of Veterinary Science, University of Pisa, San Piero a Grado, Pisa, 56122, Italy.

Search for other papers by Valentina Meucci in
Current site
Google Scholar
PubMed
Close
 ChemPharmD, PhD

Abstract

Objective—To investigate serum calcium-phosphorus concentration product (sCaPP) as a predictor of mortality rate in dogs with chronic kidney disease (CKD).

Design—Retrospective case-control study.

Animals—31 dogs with definitive CKD and 35 apparently healthy dogs.

Procedures—All dogs had been referred for nephrological consultation between December 2008 and December 2010. Dogs with CKD had stable disease for ≥ 3 months. On the basis of glomerular filtration rate < 60 mL/min/m2, 13 of the 35 apparently healthy dogs were subsequently classified as having early CKD. Disease stage among dogs was determined on the basis of plasma creatinine concentration as follows: stage 1, < 123.7 μmol/L (n = 13), stage 2, 123.7 to 176.8 μmol/L (7); stage 3, 185.6 to 442 μmol/L (13); or stage 4, > 442 μmol/L (11). For each dog, serum concentrations of ionized and total calcium and phosphorus were evaluated once; the latter 2 variables were used to determine sCaPP.

Results—The sCaPP differed significantly between the 22 healthy dogs and dogs with stage 3 or stage 4 CKD. The proportion of dogs with sCaPP > 70 mg2/dL2 increased with stage of disease. Mortality rate among the 24 dogs with sCaPP > 70 mg2/dL2 was higher than that among the 42 dogs with sCaPP ≤ 70 mg2/dL2. Dogs with sCaPP > 70 mg2/dL2 had a comparatively lower survival rate, and risk of death was 4.2 times as high as risk for dogs with sCaPP ≤ 70 mg2/dL2.

Conclusions and Clinical Relevance—For dogs with CKD, sCaPP > 70 mg2/dL2 appeared to be a negative prognostic indicator, which was not influenced by the concomitant serum concentrations of phosphorus and total or ionized calcium.

Abstract

Objective—To investigate serum calcium-phosphorus concentration product (sCaPP) as a predictor of mortality rate in dogs with chronic kidney disease (CKD).

Design—Retrospective case-control study.

Animals—31 dogs with definitive CKD and 35 apparently healthy dogs.

Procedures—All dogs had been referred for nephrological consultation between December 2008 and December 2010. Dogs with CKD had stable disease for ≥ 3 months. On the basis of glomerular filtration rate < 60 mL/min/m2, 13 of the 35 apparently healthy dogs were subsequently classified as having early CKD. Disease stage among dogs was determined on the basis of plasma creatinine concentration as follows: stage 1, < 123.7 μmol/L (n = 13), stage 2, 123.7 to 176.8 μmol/L (7); stage 3, 185.6 to 442 μmol/L (13); or stage 4, > 442 μmol/L (11). For each dog, serum concentrations of ionized and total calcium and phosphorus were evaluated once; the latter 2 variables were used to determine sCaPP.

Results—The sCaPP differed significantly between the 22 healthy dogs and dogs with stage 3 or stage 4 CKD. The proportion of dogs with sCaPP > 70 mg2/dL2 increased with stage of disease. Mortality rate among the 24 dogs with sCaPP > 70 mg2/dL2 was higher than that among the 42 dogs with sCaPP ≤ 70 mg2/dL2. Dogs with sCaPP > 70 mg2/dL2 had a comparatively lower survival rate, and risk of death was 4.2 times as high as risk for dogs with sCaPP ≤ 70 mg2/dL2.

Conclusions and Clinical Relevance—For dogs with CKD, sCaPP > 70 mg2/dL2 appeared to be a negative prognostic indicator, which was not influenced by the concomitant serum concentrations of phosphorus and total or ionized calcium.

All Time Past Year Past 30 Days
Abstract Views 414 0 0
Full Text Views 1498 1106 48
PDF Downloads 655 333 38
Advertisement